Development (1) Treatment (1) Price-earnings ratio (1) Antipsychotic drugs (1) Wealth (1) Tranquilizing drugs (1) Sealing (Technology) (1) Schizophrenia (1) Psychiatrists (1) Pension trusts (1) Mass media (1) Impact (1) Special education (1) Average (1) Adhesions (1) Adhesion (1) Sizes (1) Rates (1) Prognosis (1) Patients (1) Quality (1) Effectiveness (1) Risk factors (1) Adhesión (1) Ansiolíticos (1) Psiquiatras (1) Pronóstico médico (1) Neurolépticos (1) Esquizofrenia (1) Educación especial (1)